Genenta Science
GNTA
2 hedge funds and large institutions have $274K invested in Genenta Science in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
4% more capital invested
Capital invested by funds: $264K → $274K (+$9.36K)
0.02% less ownership
Funds ownership: 0.27% → 0.25% (-0.02%)
50% less funds holding
Funds holding: 4 → 2 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$17.7K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1.89K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AU
1
Algebris (UK)
London,
United Kingdom
| $271K | – | – | – |
|
2
Morgan Stanley
New York
| $2.9K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$17.7K | -3,215 | Closed |
|
|
4
Bank of America
Charlotte,
North Carolina
| – | -$1.89K | -343 | Closed |
|
GNTA Hedge Fund Activity: Q1 2023 in Review
2 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q1 2023, worth a combined $274K — up 3.5% from $264K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of GNTA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $17.7K sold.
- 2 institutional investors held Genenta Science (GNTA) as of Q1 2023, down from 4 in Q4 2022.
- Funds reported $274K of Genenta Science stock for Q1 2023, up 3.5% quarter-over-quarter.
- 0 funds opened new Genenta Science positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest Genenta Science seller in Q1 2023 was UBS Group, an estimated $17.7K sold.
Based on aggregated 13F filings for Q1 2023.